Contrast Media
Aims of this session







Why contrast agents are used
What are the desirable features of a contrast agent
Types of contrast agents used in clinical settings
Methods of administrating contrast agents
Examples of examinations utilising contrast agents
Problems/issues associated with administrating
contrast agents

2
Contrast


The difference in optical density
between different parts of an image
on a radiograph. It is a reflection of
the different absorption coefficients
and bulk of different regions of the
part being radiographed

3
Contrast Media
It is a chemical substance of very high or
very low atomic number or weight, there
for it increase or decrease the density of
the organ under examination.
“Contrast Media"
– substance placed
in the body to
provide added
contrast when
subject contrast is
low
– increases the
radiographic
contrast between
the area
containing the CM
& areas not
containing CM

UNIT VII

Without
CM

With
CM
5
Contrast Media


A substance which when introduced
into the body will increase the
radiographic contrast in an area
where it was absent or low before.

6
Brief History








1897 - First reported GI contrast study performed Bismuth - TOXIC!
1910 - Barium Sulphate used (safer)
1920’s - Sodium Iodide used to treat syphilis.
Iodine was found to be radio opaque to x-rays.
Bases of all modern contrast agents.
1927 - First reported IVU with iodised organic salts
(Uroselectan)

7
Requirements of a Contrast Agent (1)
Easy to administer
 No toxicity
 Stable compound. – Will not dissociate into
toxic ions
 When injected the media concentrates in
area(s) required
 The agent’s physical features allow the organ
to be properly demonstrated e
- even barium coating of the stomach in the
presence of an acid environment .




8
Requirements of a contrast agent (2)
 The

agent should have rapid elimination.
 The agent should not be carcinogenic.
 The agent should have a viscosity
appropriate to the patient when
introduced.
 The agent should cause minimal distress
to the patient when introduced.
 The agent should be cost-effective.
9
Methods of administration
 Orally.
 Rectally.
 Intra-

venously – (injection /
infusion).
 Mechanically – Filling of a body
cavity or potential space.
 Intra-muscularly.

10
Examples of areas where contrast
agents are used












Arteriography
Angiography (DSA) – Cardiology
Venography (replaced by ultrasoundDoppler)
IVU
Fluoroscopy – Alimentary tract,
hyserosalpingography, sialography,
Computerised Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound – Liver, kidney
Myelography (replaced by MRI)
Arthrography – Knee joints.

11
Contrast Media
C.M

Negative
Air & its constitution

Positive

Iodine compound

Oily

Bso4
GIT

Powder

Water soluble
Types of contrast media


Negative Contrast Agents
- Air
- CO 2
- O2

13
How do negative contrast agents
perform?




The negative contrast agents
reduce the atomic number of the
area to be demonstrated.
These types of contrast media
will have little attenuation of the
x-ray beam.

14
Positive Contrast Agents



Barium based
Iodine based agents
– Water soluble (Niopam)
– Non soluble (Lipiodol, Myodol)

The positive contrast agents increase the atomic number

of the area to be demonstrated in relation to the
surrounding tissue.
15
• Powder contrast in a form of tablets e.g.
Biloptin, Cistobil.
• Oily contrast e.g. myodil, dinosil & lipidol.
• Water soluble ( addition of sugar).
.
Ionic e.g. urografine, urovideo, uromiro,
conray, hexbric & angoigrafine.
Non ionic e.g. Amipaque, omnipaque,
ultravist & isovist.
Note:- all nonionic C.M. are more safety
than ionic one.
• Water soluble C.M. found in different
concentration per ml so you must
check it carefully to calculate the dose.
Contraindications Iodine
(DO NOT USE)
hypersensitivity to iodine
heart or renal failure
liver disease
Double contrast agents
Incorporates the use of both positive &
negative contrast media.
eg during a double contrast Barium enema
examination.





Co 2 + BaSo 4

= Double Contrast
21
Why use Barium Sulphate?






It has a high atomic
number (Z=56)
Non-toxic
Relatively cheap
Inert

22
Pharmacological agents




Buscopan
Glucagon
Maxalon




Why are they given?
23
Pharmacological agents


Buscopan (20mg iv) & Glucagon (0.3mg iv)
both relax smooth muscle (Glucagon more
potent & can be used on patients with
glaucoma & cardiovascular disease).
Useful in barium enema examinations.



Maxalon (20mg iv/oral) increases gastric
peristalsis
(useful in follow through examinations)
24
Iodine based contrast agents
(1)


Approximately 90% of all contrast media
used in x-ray imaging are loosely termed
intravascular or general contrast media.



The physical properties of the iodine based
contrast media include the ions or particles
associated with the chemical breakdown of
the contrast media when it enters a
solution.
25
Iodine based contrast agents
(2)








The chemical composition of ionic & non-ionic
contrast media contains iodine.
On its own, iodine is unsuitable as a contrast
agent as it toxic!
The answer is to attach iodine to a “carrier”
molecule
Achieved by basing the molecule on the
benzene ring & replacing the carbon atoms at
set points with iodine to produce tri-iodinated
benzoic rings
26
Ionic Contrast Agents



An ionic compound dissociates
(dissolves) into charged particles
when it enters a solution (ie blood)



Ionic media breakdown into cations
(+ive charged particles) & anions (-ive
charged particles)


27
Ionic Contrast Agents






An ionic contrast agent has approximately
five times the osmolarity of human plasma
(hyperosmolar)
The iodine atoms provide the attenuation
properties
The additional chemical groups determine the
properties of the contrast agent, ie solubility,
toxicity, viscosity, osmolarity.
–
28
Osmolarity


The osmolarity of a solution is the measurement of
the number of molecules & particles in a solution
per kilogram of water.

29
Viscosity






Viscosity describes the
thickness or resistance to
flow of a contrast agent
The thickness of the contrast
agent is related to the
concentration, the size of the
molecules in a specific
contrast agent & the
temperature of the contrast
agent.
The viscosity affects the rate
that the contrast media can
be injected.

Q:Why are power injection (Medrad) devices fitted with warming 30
pads?




Medrad - Power Injector

Warming pad

Keeps the viscosity LOW.

31
Non-Ionic contrast media








Often referred to as “low osmolar”
Non-ionic contrast media do not dissolve into
charged particles when it enters a solution
For every three iodine molecules in a nonionic solution, one neutral molecule is
produced
Non-ionic contrast media are referred to as
3:1 compounds
32





Non-ionic contrast agents are therefore far
safer than ionic contrast agents
More expensive (++)
Non-ionic contrast agents substitute the
sodium & meg side chains with nonionising radicals (NIR ).
Gastrograffin & Gastromiro







Water soluble iodine based contrast agents
Designed especially for G.I. use
Characteristic aniseed taste.
Particularly useful in neonates & paediatrics
Isotonic at iodine concentrations (Gastromiro).
– Gastrograffin = (370 mg ml -1 )
– Gastromiro = (300 mg ml -1 )






Satisfactory for good images of the bowel
Recommended for use where there is a
suspected leakage into pleural or peritoneal
cavities.
Also useful in CT to distinguish bowel from other
34
structures(15ml in 1 litre)
Recent development of contrast
agents (1)


Current contrast agents reaching the critical
iso-osmolarity stage within the human body



Increased hydrophilicity due to an
increased number of hydroxyl groups
provides a high affinity for water and
shelters the toxic iodine atoms from the
human body.



Particularly useful for paediatrics & hypersensitive patients.

35
Recent development of contrast
agents(2)


MRI

Gadolinium is a rare earth metal “heavy
metal”
 Gadolinium is chelated to DTPA
(Magnevist)
 By binding DTPA to the Gadolinium sites,
only one “free” gadolinium site is
available to attach to water molecules
 Gadolinium chelates are of small
molecular weight
 Diffuse freely & excreted by kidneys
 Typical adult dose = 0.2ml/kg (20ml max)


36
MRI – Example images

MRI (Gd-DTPA) – Hepatoblastoma

MRI (Gd- DTPA) Metastasis
37

Contrast media

  • 1.
  • 2.
    Aims of thissession       Why contrast agents are used What are the desirable features of a contrast agent Types of contrast agents used in clinical settings Methods of administrating contrast agents Examples of examinations utilising contrast agents Problems/issues associated with administrating contrast agents 2
  • 3.
    Contrast  The difference inoptical density between different parts of an image on a radiograph. It is a reflection of the different absorption coefficients and bulk of different regions of the part being radiographed 3
  • 4.
    Contrast Media It isa chemical substance of very high or very low atomic number or weight, there for it increase or decrease the density of the organ under examination.
  • 5.
    “Contrast Media" – substanceplaced in the body to provide added contrast when subject contrast is low – increases the radiographic contrast between the area containing the CM & areas not containing CM UNIT VII Without CM With CM 5
  • 6.
    Contrast Media  A substancewhich when introduced into the body will increase the radiographic contrast in an area where it was absent or low before. 6
  • 7.
    Brief History       1897 -First reported GI contrast study performed Bismuth - TOXIC! 1910 - Barium Sulphate used (safer) 1920’s - Sodium Iodide used to treat syphilis. Iodine was found to be radio opaque to x-rays. Bases of all modern contrast agents. 1927 - First reported IVU with iodised organic salts (Uroselectan) 7
  • 8.
    Requirements of aContrast Agent (1) Easy to administer  No toxicity  Stable compound. – Will not dissociate into toxic ions  When injected the media concentrates in area(s) required  The agent’s physical features allow the organ to be properly demonstrated e - even barium coating of the stomach in the presence of an acid environment .   8
  • 9.
    Requirements of acontrast agent (2)  The agent should have rapid elimination.  The agent should not be carcinogenic.  The agent should have a viscosity appropriate to the patient when introduced.  The agent should cause minimal distress to the patient when introduced.  The agent should be cost-effective. 9
  • 10.
    Methods of administration Orally.  Rectally.  Intra- venously – (injection / infusion).  Mechanically – Filling of a body cavity or potential space.  Intra-muscularly.  10
  • 11.
    Examples of areaswhere contrast agents are used            Arteriography Angiography (DSA) – Cardiology Venography (replaced by ultrasoundDoppler) IVU Fluoroscopy – Alimentary tract, hyserosalpingography, sialography, Computerised Tomography (CT) Magnetic Resonance Imaging (MRI) Ultrasound – Liver, kidney Myelography (replaced by MRI) Arthrography – Knee joints. 11
  • 12.
    Contrast Media C.M Negative Air &its constitution Positive Iodine compound Oily Bso4 GIT Powder Water soluble
  • 13.
    Types of contrastmedia  Negative Contrast Agents - Air - CO 2 - O2 13
  • 14.
    How do negativecontrast agents perform?   The negative contrast agents reduce the atomic number of the area to be demonstrated. These types of contrast media will have little attenuation of the x-ray beam. 14
  • 15.
    Positive Contrast Agents   Bariumbased Iodine based agents – Water soluble (Niopam) – Non soluble (Lipiodol, Myodol) The positive contrast agents increase the atomic number of the area to be demonstrated in relation to the surrounding tissue. 15
  • 16.
    • Powder contrastin a form of tablets e.g. Biloptin, Cistobil. • Oily contrast e.g. myodil, dinosil & lipidol. • Water soluble ( addition of sugar).
  • 18.
    . Ionic e.g. urografine,urovideo, uromiro, conray, hexbric & angoigrafine. Non ionic e.g. Amipaque, omnipaque, ultravist & isovist. Note:- all nonionic C.M. are more safety than ionic one.
  • 19.
    • Water solubleC.M. found in different concentration per ml so you must check it carefully to calculate the dose.
  • 20.
    Contraindications Iodine (DO NOTUSE) hypersensitivity to iodine heart or renal failure liver disease
  • 21.
    Double contrast agents Incorporatesthe use of both positive & negative contrast media. eg during a double contrast Barium enema examination.   Co 2 + BaSo 4 = Double Contrast 21
  • 22.
    Why use BariumSulphate?     It has a high atomic number (Z=56) Non-toxic Relatively cheap Inert 22
  • 23.
  • 24.
    Pharmacological agents  Buscopan (20mgiv) & Glucagon (0.3mg iv) both relax smooth muscle (Glucagon more potent & can be used on patients with glaucoma & cardiovascular disease). Useful in barium enema examinations.  Maxalon (20mg iv/oral) increases gastric peristalsis (useful in follow through examinations) 24
  • 25.
    Iodine based contrastagents (1)  Approximately 90% of all contrast media used in x-ray imaging are loosely termed intravascular or general contrast media.  The physical properties of the iodine based contrast media include the ions or particles associated with the chemical breakdown of the contrast media when it enters a solution. 25
  • 26.
    Iodine based contrastagents (2)     The chemical composition of ionic & non-ionic contrast media contains iodine. On its own, iodine is unsuitable as a contrast agent as it toxic! The answer is to attach iodine to a “carrier” molecule Achieved by basing the molecule on the benzene ring & replacing the carbon atoms at set points with iodine to produce tri-iodinated benzoic rings 26
  • 27.
    Ionic Contrast Agents  Anionic compound dissociates (dissolves) into charged particles when it enters a solution (ie blood)  Ionic media breakdown into cations (+ive charged particles) & anions (-ive charged particles)  27
  • 28.
    Ionic Contrast Agents    Anionic contrast agent has approximately five times the osmolarity of human plasma (hyperosmolar) The iodine atoms provide the attenuation properties The additional chemical groups determine the properties of the contrast agent, ie solubility, toxicity, viscosity, osmolarity. – 28
  • 29.
    Osmolarity  The osmolarity ofa solution is the measurement of the number of molecules & particles in a solution per kilogram of water. 29
  • 30.
    Viscosity    Viscosity describes the thicknessor resistance to flow of a contrast agent The thickness of the contrast agent is related to the concentration, the size of the molecules in a specific contrast agent & the temperature of the contrast agent. The viscosity affects the rate that the contrast media can be injected. Q:Why are power injection (Medrad) devices fitted with warming 30 pads?  
  • 31.
    Medrad - PowerInjector Warming pad Keeps the viscosity LOW. 31
  • 32.
    Non-Ionic contrast media     Oftenreferred to as “low osmolar” Non-ionic contrast media do not dissolve into charged particles when it enters a solution For every three iodine molecules in a nonionic solution, one neutral molecule is produced Non-ionic contrast media are referred to as 3:1 compounds 32
  • 33.
       Non-ionic contrast agentsare therefore far safer than ionic contrast agents More expensive (++) Non-ionic contrast agents substitute the sodium & meg side chains with nonionising radicals (NIR ).
  • 34.
    Gastrograffin & Gastromiro       Watersoluble iodine based contrast agents Designed especially for G.I. use Characteristic aniseed taste. Particularly useful in neonates & paediatrics Isotonic at iodine concentrations (Gastromiro). – Gastrograffin = (370 mg ml -1 ) – Gastromiro = (300 mg ml -1 )    Satisfactory for good images of the bowel Recommended for use where there is a suspected leakage into pleural or peritoneal cavities. Also useful in CT to distinguish bowel from other 34 structures(15ml in 1 litre)
  • 35.
    Recent development ofcontrast agents (1)  Current contrast agents reaching the critical iso-osmolarity stage within the human body  Increased hydrophilicity due to an increased number of hydroxyl groups provides a high affinity for water and shelters the toxic iodine atoms from the human body.  Particularly useful for paediatrics & hypersensitive patients. 35
  • 36.
    Recent development ofcontrast agents(2)  MRI Gadolinium is a rare earth metal “heavy metal”  Gadolinium is chelated to DTPA (Magnevist)  By binding DTPA to the Gadolinium sites, only one “free” gadolinium site is available to attach to water molecules  Gadolinium chelates are of small molecular weight  Diffuse freely & excreted by kidneys  Typical adult dose = 0.2ml/kg (20ml max)  36
  • 37.
    MRI – Exampleimages MRI (Gd-DTPA) – Hepatoblastoma MRI (Gd- DTPA) Metastasis 37